Internal Medicine, Rheumatology · Wilmington, NC
NPI
1265657894
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2421 Silver Stream Ln
Wilmington, NC, 28401
Phone (910) 341-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
190,738 services
Medicare patients, 2024
766
Average age 72
Drug cost, 2024
$10.0M
7,044 prescriptions
Company payments, 2025
$2,502
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald L George Jr. was code J3262 (injection, tocilizumab, 1 mg), 72,396 times for 25 patients. In total Ronald L George Jr. billed 190,738 services in 111 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 72,396 | 25 | $4.73 | $343K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 27,200 | 18 | $3.65 | $99K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 23,400 | 41 | $9.12 | $213K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,350 | 26 | $33.77 | $350K |
| J0897 Injection, denosumab, 1 mg | Office | 4,080 | 47 | $20.25 | $83K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,264 | 21 | $24.93 | $81K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,145 | 123 | $0.74 | $844 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 990 | 17 | $0.22 | $220 |
| 99214 Office E&M - Established | Office | 944 | 529 | $86.76 | $82K |
| 36415 Venipuncture Blood Collection | Office | 865 | 504 | $8.65 | $7,482 |
| 85652 Clinical Chemistry | Office | 742 | 451 | $2.63 | $1,952 |
| 80053 Clinical Chemistry | Office | 724 | 462 | $10.28 | $7,444 |
| 86140 Clinical Chemistry | Office | 710 | 442 | $5.05 | $3,583 |
| 96365 Intravenous Infusion, Hydration | Office | 685 | 225 | $40.88 | $28K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 495 | 99 | $4.31 | $2,132 |
By year: 2022 $3.4M for 269,168 services; 2023 $3.2M for 339,636 services; 2024 $1.8M for 190,738 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 865 | 504 | $8.65 | $7,482 |
| 85652 Clinical Chemistry | 742 | 451 | $2.63 | $1,952 |
| 80053 Clinical Chemistry | 724 | 462 | $10.28 | $7,444 |
| 86140 Clinical Chemistry | 710 | 442 | $5.05 | $3,583 |
| 86160 Immunoassay | 146 | 58 | $11.76 | $1,717 |
| 82306 Clinical Chemistry | 85 | 70 | $29.01 | $2,466 |
| 86200 Immunoassay | 40 | 40 | $12.44 | $498 |
| 84550 Clinical Chemistry | 40 | 31 | $4.43 | $177 |
| 86431 Immunoassay | 39 | 39 | $5.45 | $213 |
| 86705 Immunoassay | 34 | 34 | $11.53 | $392 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald L George Jr. prescribed most often to Medicare patients was Prednisone, with 1,186 prescriptions and refills. In total Ronald L George Jr. wrote 7,044 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,186 | 1,656 | 316 | $6,594 |
| Hydroxychloroquine Sulfate Generic | 1,054 | 2,093 | 248 | $30K |
| Methotrexate Methotrexate Sodium | 900 | 1,641 | 216 | $17K |
| Humira(Cf) Pen Adalimumab | 257 | 259 | 46 | $1.8M |
| Celecoxib Generic | 230 | 323 | 52 | $4,452 |
| Duloxetine Hcl Generic | 203 | 448 | 44 | $3,598 |
| Sulfasalazine Dr Sulfasalazine | 170 | 299 | 46 | $5,216 |
| Leflunomide Generic | 161 | 362 | 54 | $13K |
| Enbrel Sureclick Etanercept | 155 | 155 | 23 | $1.1M |
| Gabapentin Generic | 136 | 209 | 36 | $1,640 |
| Mycophenolate Mofetil Generic | 128 | 245 | 34 | $13K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 123 | 125 | 27 | $994K |
| Azathioprine Generic | 117 | 205 | 25 | $4,538 |
| Allopurinol Generic | 110 | 298 | 35 | $1,202 |
| Rinvoq Upadacitinib | 107 | 119 | 22 | $771K |
Brand drugs: 1,558 claims; generic drugs: 5,486 claims; opioid claims: 213.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald L George Jr. $2,502 ($2,502 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $508.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.